Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2B | Q14289 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30140858 | 1.00 | PTK2B (0.45) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL27985462 | 0.98 | PTK2B (0.44) | PTK2BMEN1KMT2APKMCXCL8 | |
| Hydrochloric Acid SCHEMBL27850668 | 0.98 | PTK2B (0.44) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL28122214 | 0.98 | PTK2B (0.44) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL5842469 | 0.85 | MRGPRX4 (0.43) | MEN1KMT2AHTTTP53L3MBTL1 | |
| SCHEMBL8496813 | 0.84 | PTK2B (0.47) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL28189795 | 0.82 | MEN1 (0.50) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL27645038 | 0.82 | KMT2A (0.46) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL8498810 | 0.81 | KMT2A (0.50) | PTK2BMEN1KMT2APKMCXCL8 | |
| SCHEMBL578720 | 0.81 | ELANE (0.46) | PTK2BMEN1KMT2APKMCXCL8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115784914-A | Preparation method of o-chlorophenylglycine | 石家庄中硕科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-218307945-U | Synthesis device for preparing o-chlorobenzene glycine intermediate | 抚顺顺能化工有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-114853623-A | Preparation method of S- (+) -o-chlorophenylglycine methyl ester tartrate | 河南优凯制药有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114685300-A | Preparation method of o-chlorophenylglycine | 抚顺顺能化工有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114507650-A | Leucine dehydrogenase mutant and application thereof in synthesis of (S) -o-chlorophenylglycine | 浙江工业大学 | 2022-05-17 | — | — | CN | claimed |
| CN-213866023-U | O chlorobenzene glycine decoloration equipment | 黑龙江泰纳科技集团股份有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-111440139-A | Preparation method of clopidogrel sulfonate impurity | 廊坊市泽康医药科技有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-107628955-B | Amino inhibitor for water-based drilling fluid, water-based drilling fluid system and preparation method | 中国石油集团长城钻探工程有限公司钻井液公司 | 2020-06-02 | — | — | CN | claimed |
| CN-210495690-U | A dust collecting equipment for producing o-chlorobenzene glycine | 石家庄中硕科技有限公司 | 2020-05-12 | — | — | CN | claimed |
| CN-210496365-U | Preparation facilities of o chlorobenzene glycine | 石家庄中硕科技有限公司 | 2020-05-12 | — | — | CN | claimed |
| CN-101560533-A | Preparation method of S-(+)-o-chlorobenzoyl glycine | SUZHOU LIXIN PHARMACEUTICAL CO (CN) | 2009-10-21 | — | — | CN | claimed |
| CN-100548969-C | A kind of preparation method of o-chlorobenzene glycine | ZHEJIANG PULUO MEDICINE TECHNO (CN) | 2009-10-14 | — | — | CN | claimed |
| EP-2078025-A2 | PROCESS FOR THE SYNTHESIS OF CLOPIDOGREL AND NEW FORMS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | KRKA, tovarna zdravil, d.d., Novo mesto (SI) | 2009-07-15 | — | — | EP | claimed |
| CN-101368199-A | Method for preparing D-aminophenol with immobilization penicillin acylated enzyme catalysis | UNIV CHONGQING POSTS & TELECOM (CN) | 2009-02-18 | — | — | CN | claimed |
| WO-2008034912-A2 | PROCESS FOR THE SYNTHESIS OF CLOPIDOGREL AND NEW FORMS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2008-03-27 | — | — | WO | claimed |
| CN-101092379-A | Method for synthesizing optically active laevogyrate and dexiotropous camphor sulfonic acid | KANGFUSAIER MEDICINES TECH CO (CN) | 2007-12-26 | — | — | CN | claimed |
| CN-101058547-A | Method of preparing o-chlorophenyl glycine | ZHEJIANG PULUO MEDICINE TECHNO (CN) | 2007-10-24 | — | — | CN | claimed |
| WO-2007094006-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM 1 | LEE PHARMA LIMITED (IN) | 2007-08-23 | — | — | WO | claimed |
| US-20070191609-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 | LEE PHARMA LIMITED (IN) | 2007-08-16 | — | — | US | claimed |
| CN-101003822-A | Method for producing D amino acid by immobilizing acylation enzyme of penicillin | CHENGDU ORGANIC CHEMISTRY C A (CN) | 2007-07-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191609-A1 | PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 | SULT1A1, SF1, ADH1C | PTK2B 646/4885MEN1 2059/4885KMT2A 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.